Opus Genetics, Inc.Opus Genetics, Inc.Opus Genetics, Inc.

Opus Genetics, Inc.

No trades
See on Supercharts

Price target

9.000.000.00%
The 3 analysts offering 1 year price forecasts for IRD have a max estimate of — and a min estimate of —.

Analyst rating

Based on 3 analysts giving stock ratings to IRD in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


IRD EPS for the last quarter is −0.29 USD despite the estimation of −0.24 USD. In the next quarter EPS is expected to reach 0.02 USD. Track more of Opus Genetics, Inc. financials and stay on top of what is up with the company.
In the next quarter Opus Genetics, Inc. revenue is expected to reach ‪11.11 M‬ USD. Check out Opus Genetics, Inc. revenue and earnings and make informed decisions.
According to analysts, IRD price target is 9.00 USD with a max estimate of 10.00 USD and a min estimate of 8.00 USD. Check if this forecast comes true in a year, meanwhile watch Opus Genetics, Inc. stock price chart and keep track of the current situation with IRD news and stock market news.